Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

Action in Brussels on GMO risk assessment meeting

This morning, about 40 activists and concerned citizens handed out flyers to participants to a closed-doors meeting of the Standing Committee on the Food Chain and Animal Health (SCFCAH), gathering representatives of the European Commission and Member States in the Borschette conference centre, rue Froissard 36 in Brussels.

The meeting's agenda contained a key item: the draft regulation which, if voted today, would define how GMOs' harmfulness should be assessed in the EU. This regulation is based on EFSA guidelines which were written by scientists with conflicts of interests with industry: if voted today, the regulation would guarantee that risk assessment protocols used for GMOs risk assessment in the EU are unlikely to detect any undesired effect. The meeting comes at a strategic moment as GMOs risk assessment is one of the key items in the US-EU free trade talks due to be launched any moment soon.

 

  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska

Food and feed safety must be based on science, not on the interests of the biotechnology industry! 

  • Our health cannot be sacrified to free trade agreements and biotech industry interests
  • The draft regulation being discussed today lets “stacked events” off the hook and enshrines dodgy risk assessment protocols first drafted by scientists with conflicts of interests with industry
  • The 27 GM crops whose authorisation for cultivation in the EU is still pending would not even comply to the mandatory toxicology tests foreseen by this regulation; however, the text does not apply to them! 

Today's closed-doors meeting of the EU's Standing Committee on the Food Chain and Animal Health (SCFCAH), involving only officials of the European Commission and Member States, will deal with a crucial text: a regulation describing how the potential toxicity of GMOs should be assessed [1]. Based on EFSA guidelines written by scientists with conflicts of interests with the biotechnology industry [2] and vaguely improved by the Commission, the current draft regulation is flawed and will only make sure that risk assessment protocols used for GMOs risk assessment in the EU are unable to detect any undesired effect: studies on rats are only required to last 90 days (when recent studies indicated severe effects only appeared after at least a year, leading numerous scientists and national experts to call for longer studies than these industry-favoured 90 days[3]), and “stacked” crops (GM crops with several genetical modifications) are spared separate testing. 

But even though these protocols are flawed, they remain comparatively better than those used by industry to evaluate the 27 GM crops whose authorisation is currently pending in the EU system[4]. However, this regulation does not apply to these. Why such haste in deciding on useless food safety protocols? One answer could be free trade: the European Commission strongly pushes to sign a USA-EU free trade deal, hoping it will help the EU out of the ongoing crisis; but GMOs risk assessment is a key point in the debate5, because the US' GMOs risk assessment regime is even weaker than the EU's and the US do not want to risk undermining the interests of their biotech companies. 

However, we consider that sacrifying our health and our environment to short-term trade objectives and the irresponsible greed of biotech companies is not an option. 

1 Draft Commission implementing Regulation on implementing rules concerning applications for authorisation of genetically modified food and feed in accordance with Regulation (EC) No 1829/2003 of the European Parliament and of the Council and amending Regulations No (EC) 641/2004 and (EC) No 1981/2006. 

2 Led by ILSI scientist Harry Kuiper, see http://www.monsanto.no/index.php/en/environment/gmo/gmo-news/166-harry-k...  

3 Séralini's study on rats fed with Monsanto GM corn, also on the meeting's agenda, has been dismissed in a coordinated effort by EFSA and national food safety agencies; however, many independent scientists and strong minority opinions within Belgium, France and Germany's food safety agencies acknowledged the quality of the study's design and its relevance to the subject, calling for similar long-term studies. 

4 These studies' statistical power is way too low to enable any meaningful toxicity conclusion and would not even pass the weak requirements foreseen in the regulation. 

http://www.eubusiness.com/news-eu/us-economy-trade.mda 

   

Food and feed safety must be based on science, not on the interests of the biotechnology industry! Our health cannot be sacrified to free trade agreements and biotech industry interestsThe draft regulation being discussed today lets “stacked events” off the hook and enshrines dodgy risk assessment protocols first drafted by scientists with conflicts of interests with industryThe 27 GM crops whose authorisation for cultivation in the EU is still pending would not even comply to the mandatory toxicology tests foreseen by this regulation; however, the text does not apply to them! Today's closed-doors meeting of the EU's Standing Committee on the Food Chain and Animal Health (SCFCAH), involving only officials of the European Commission and Member States, will deal with a crucial text: a regulation describing how the potential toxicity of GMOs should be assessed [1]. Based on EFSA guidelines written by scientists with conflicts of interests with the biotechnology industry [2] and vaguely improved by the Commission, the current draft regulation is flawed and will only make sure that risk assessment protocols used for GMOs risk assessment in the EU are unable to detect any undesired effect: studies on rats are only required to last 90 days (when recent studies indicated severe effects only appeared after at least a year, leading numerous scientists and national experts to call for longer studies than these industry-favoured 90 days[3]), and “stacked” crops (GM crops with several genetical modifications) are spared separate testing. But even though these protocols are flawed, they remain comparatively better than those used by industry to evaluate the 27 GM crops whose authorisation is currently pending in the EU system[4]. However, this regulation does not apply to these. Why such haste in deciding on useless food safety protocols? One answer could be free trade: the European Commission strongly pushes to sign a USA-EU free trade deal, hoping it will help the EU out of the ongoing crisis; but GMOs risk assessment is a key point in the debate5, because the US' GMOs risk assessment regime is even weaker than the EU's and the US do not want to risk undermining the interests of their biotech companies. However, we consider that sacrifying our health and our environment to short-term trade objectives and the irresponsible greed of biotech companies is not an option. 1 Draft Commission implementing Regulation on implementing rules concerning applications for authorisation of genetically modified food and feed in accordance with Regulation (EC) No 1829/2003 of the European Parliament and of the Council and amending Regulations No (EC) 641/2004 and (EC) No 1981/2006. 2 Led by ILSI scientist Harry Kuiper, see http://www.monsanto.no/index.php/en/environment/gmo/gmo-news/166-harry-k...  3 Séralini's study on rats fed with Monsanto GM corn, also on the meeting's agenda, has been dismissed in a coordinated effort by EFSA and national food safety agencies; however, many independent scientists and strong minority opinions within Belgium, France and Germany's food safety agencies acknowledged the quality of the study's design and its relevance to the subject, calling for similar long-term studies. 4 These studies' statistical power is way too low to enable any meaningful toxicity conclusion and would not even pass the weak requirements foreseen in the regulation. 5 http://www.eubusiness.com/news-eu/us-economy-trade.mda    
 
To prevent automated spam submissions leave this field empty.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

An analysis of the revised independence policy of the European Food Safety Authority (EFSA). More reworded than revised, actually.
Will EFSA become more transparent, and to lobbyists or scientists? After its public consultation on its draft transparency policy, the Authority must now choose.
This must-watch film is now online. The film shows how corporations and actors within the Commission are teaming up to demolish a major piece of public health legislation.
Campaign groups today called on members of the European Parliament to back citizens' demands for improved rules to prohibit the cultivation of genetically modified (GM) crops. A letter signed by five environment, consumers and farmers groups was sent to all members of the parliament's environment committee, which will debate this controversial issue later in the week.
An analysis of the revised independence policy of the European Food Safety Authority (EFSA). More reworded than revised, actually.
The EU's Comprehensive Economic and Trade Agreement (CETA) with Canada could unleash a wave of corporate lawsuits against Canada, the EU and its member states – including through the Canadian subsidiaries of US multinational corporations. This is the result of an in-depth analysis of CETA’s investor rights by Corporate Europe Observatory and 14 other environmental NGOs, citizens’ groups and workers unions from both sides of the Atlantic published today.
The position of Chief Scientific Adviser to the President of the European Commission has been discontinued, and the Juncker Commission says it is now reflecting on how to organise independent scientific advice. This is a crucial issue and, together with many other NGOs, we sent a list of principles to the Commission on how to, in our opinion, try to best do this.
This 10-minute video exposes the role corporate lobbies have in EU decision-making, how they manage to get what they want and how their activities affect citizens all over Europe.

Corporate Europe Forum